Stock GLYC GLYCOMIMETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
1.64 USD -4.09% Intraday chart for GlycoMimetics, Inc. -14.81% -30.51%
03-27 Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024
03-27 GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on GlycoMimetics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2aa9e87173c8cf51d8e977556cbfb.PIHEYKSjUoFtVmJyAP51aDRmLsU627OLqFHI1Q-q1tE.WfudEJaWG-g_Jy4kdoY_EkIzQKdQr-ru-huCnmXLsodLtfwn7MEV9lo4Mw~b5101b2279b3d68a3bf4303fe7c2f7bc

Analyst Recommendations on GlycoMimetics, Inc.

Capital One Initiates GlycoMimetics With Overweight Rating, Price Target is $12 MT
HC Wainwright Adjusts GlycoMimetics Price Target to $13 From $14, Maintains Buy Rating MT
Jefferies Raises GlycoMimetics to Buy From Hold, Price Target to $4 From $3 MT
GLYCOMIMETICS : Roth Capital Adjusts GlycoMimetics' Price Target to $15 From $9, Reiterates Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.64 USD
Average target price
7 USD
Spread / Average Target
+326.83%
High Price Target
10 USD
Spread / Highest target
+509.76%
Low Price Target
3 USD
Spread / Lowest Target
+82.93%

Consensus detail

Consensus revision (last 18 months)

Analysts covering GlycoMimetics, Inc.

Capital One Securities
HC Wainwright
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GLYC Stock
  4. Consensus GlycoMimetics, Inc.